Articles with "mutated cells" as a keyword



Direct evidence for the age-dependent demise of GNAS-mutated cells in oral fibrous dysplasia.

Sign Up to like & get
recommendations!
Published in 2018 at "Archives of oral biology"

DOI: 10.1016/j.archoralbio.2018.05.018

Abstract: OBJECTIVE Fibrous dysplasia (FD) is a benign bone disease characterized by fibro-osseous lesions. FD is caused by somatic mutations in the gene, guanine nucleotide-binding protein, alpha stimulating activity polypeptide 1 (GNAS), which encodes the G… read more here.

Keywords: age dependent; evidence age; mutated cells; fibrous dysplasia ... See more keywords

High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells

Sign Up to like & get
recommendations!
Published in 2021 at "Blood Cancer Journal"

DOI: 10.1038/s41408-021-00531-2

Abstract: Mutations of calreticulin (CALR) are the second most prevalent driver mutations in essential thrombocythemia and primary myelofibrosis. To identify potential targeted therapies for CALR mutated myeloproliferative neoplasms, we searched for small molecules that selectively inhibit… read more here.

Keywords: atr chk1; calr mutated; mutated cells; calr ... See more keywords

Targeting IDH1-Mutated Malignancies with NRF2 Blockade.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of the National Cancer Institute"

DOI: 10.1093/jnci/djy230

Abstract: Background Neomorphic IDH1 mutations disrupt the redox balance by promoting reactive oxygen species (ROS) production. However, the mechanism by which IDH1-mutant cells maintain ROS homeostasis remains elusive. It is also not known whether reprogrammed ROS… read more here.

Keywords: nrf2 blockade; mutated cells; idh1 mutated; idh1 ... See more keywords

Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage

Sign Up to like & get
recommendations!
Published in 2025 at "Cancer Discovery"

DOI: 10.1158/2159-8290.cd-24-1379

Abstract: Tumor initiation, via either chemical mutagens or genetic models of Ras activation, produces long-lived, but latent, mutated cells that require chronic tumor promoter exposure to form cancers. read more here.

Keywords: long term; highly mutated; term latency; tumor ... See more keywords